Kavoussi Parviz K, Atmoko Widi, Pinggera Germar-Michael
Department of Reproductive Urology, Austin Fertility and Reproductive Medicine/Westlake IVF, Austin, TX 78746, USA.
Department of Urology, Faculty of Medicine, University of Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia.
Asian J Androl. 2025 May 1;27(3):375-382. doi: 10.4103/aja202450. Epub 2024 Aug 16.
Nonobstructive azoospermia (NOA) is considered the most challenging clinical scenario for infertile men and current treatments leave many men unsuccessful at being able to achieve a pregnancy with their partner using their own sperm. Microdissection testicular sperm extraction (micro-TESE) is the choice for men with NOA desiring to father children with their own gametes. Micro-TESE results in the highest numbers of sperm cells retrieved for use with in vitro fertilization/intracytoplasmic sperm injection. With suboptimal micro-TESE success rates of sperm retrieval and then pregnancy and live birth using the retrieved sperm with in vitro fertilization/intracytoplasmic sperm injection, advances to improve outcomes are necessary. This article comprehensively reviews the technologies investigated to date to improve the outcomes for men undergoing micro-TESE.
非梗阻性无精子症(NOA)被认为是不育男性面临的最具挑战性的临床情况,目前的治疗方法使许多男性无法通过自身精子与伴侣成功受孕。显微外科睾丸精子提取术(micro-TESE)是希望用自身配子生育子女的NOA男性的选择。Micro-TESE能获取数量最多的精子细胞用于体外受精/卵胞浆内单精子注射。鉴于micro-TESE在精子获取以及随后使用获取的精子进行体外受精/卵胞浆内单精子注射的妊娠和活产成功率不尽人意,有必要改进技术以提高治疗效果。本文全面综述了迄今为止为改善接受micro-TESE男性的治疗效果而研究的技术。